,,ii  #aahth ,,congress  #ast ,session  
,s4 #aahb  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,april #ah1    
#bjbc,mr4 ,kennedy introduced the       
following bill2 which was read twice and
 referred to the ,committee on ,health1 
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to amend the ,public ,health   
,service ,act to increase the           
transparency and accountability of the  
drug discount program1 and for other    
purposes4  #a4 ,short title ,this ,act  
may be cited as the #cdj;,b ,reporting  
and ,accountability ,act4  #b4          
,requirement to provide drug discounts  
to patients  7a7 ,in general ,section   
#cdj;,b7a77#e7 of the ,public ,health   
,service ,act 7#db ,u4,s4,c4            
#bef;b7a77#e77 is amended-- 7#a7 in     
subparagraph 7,c71 by striking          
subparagraphs 7,a7 or 7,b7 and inserting
 subparagraph 7,a71 7,b71 or 7,e72  7#b7
 in subparagraph 7,d71 by striking      
subparagraphs 7,a7 or 7,b7 and inserting
 subparagraph 7,a71 7,b71 or 7,e72 and  

7#c7 by adding at the end the following3
  7,e7 ,requirement to provide drug     
discounts to patients ,a covered entity 
shall ensure that each patient who      
receives a covered outpatient drug from 
such covered entity is provided such    
drug at a price that does not exceed the
 price at which the covered entity      
purchased the drug in accordance with   
paragraph 7#a71 less any additional     
discounts or rebates received by the    
covered entity with respect to the drug4
  4  7b7 ,reporting requirements for    
drug discount program ,section          
#cdj;,b7d77#b77;,b7 of the ,public      
,health ,service ,act 7#db ,u4,s4,c4    
#bef;b7d77#b77;,b77 is amended by adding
 at the end the following3  7vi7 7,i7   
,not later than #a year after the date  
of enactment of the #cdj;,b ,reporting  
and ,accountability ,act1 the           
development of procedures to require    
each covered entity to report to the    
,secretary1 not less frequently than    
annually1 information on-- 7aa7 the     

total amount paid by the covered entity 
during the reporting period for covered 
outpatient drugs under subsection 7a72  
7bb7 the total amount received by the   
covered entity during the reporting     
period for such covered outpatient      
drugs2 and  7cc7 if a covered entity    
receives any revenue as a result of     
charging a price for a covered          
outpatient drug that exceeds the price  
at which the covered entity purchased   
the drug1 how the covered entity spent  
such revenue4  7,,ii7 ,the ,secretary   
shall make the information reported     
under subclause 7,i7 publicly available4
  4